Early changes of ganglion cell-inner plexiform layer thickness and macular microvasculature in Posner-Schlossman syndrome: a binocular control study by OCTA.
Posner-Schlossman syndrome (PSS)
macular ganglion cell-inner plexiform layer (mGCIPL)
macular superficial microvasculature
optical coherence tomography angiography (OCTA)
perfusion density (PD)
vessel density (VD)
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
02
2023
accepted:
10
07
2023
medline:
9
8
2023
pubmed:
9
8
2023
entrez:
9
8
2023
Statut:
epublish
Résumé
To evaluate the early changes in ganglion cell-inner plexiform layer thickness and macular microvasculature in Posner-Schlossman syndrome (PSS) with a binocular control study involving optical coherence tomography angiography (OCTA). Twenty-six patients with unilateral PSS were included in this cross-sectional study. All subjects underwent a thorough ocular examination. Macular ganglion cell-inner plexiform layer (mGCIPL) and superficial macular microvasculature measurements, including vessel density (VD), perfusion density (PD) and the foveal avascular zone (FAZ), were recorded. In PSS-affected eyes, the mGCIPL thickness was significantly lower in all quadrants than in the contralateral eyes (all
Identifiants
pubmed: 37554506
doi: 10.3389/fmed.2023.1169504
pmc: PMC10405927
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1169504Informations de copyright
Copyright © 2023 Hu, Zhu, Xu, Wei, Wu, Dai and Xu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2017 Aug 31;12(8):e0184297
pubmed: 28859176
Curr Eye Res. 2020 May;45(5):629-635
pubmed: 31587582
Ophthalmol Glaucoma. 2020 Jan-Feb;3(1):66-75
pubmed: 32632406
Ophthalmology. 2018 Apr;125(4):578-587
pubmed: 29174012
Biomed Res Int. 2023 Jan 20;2023:4110344
pubmed: 36714029
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3757-3767
pubmed: 34296346
Ophthalmic Res. 2018;60(3):139-151
pubmed: 29794471
Am J Ophthalmol. 2017 May;177:106-115
pubmed: 28254626
Ophthalmology. 2001 May;108(5):913-8
pubmed: 11320022
PLoS One. 2020 Jun 25;15(6):e0234816
pubmed: 32584833
J Ophthalmol. 2019 Jan 15;2019:7419470
pubmed: 30766730
Prog Retin Eye Res. 2017 Sep;60:66-100
pubmed: 28760677
Arch Ophthal. 1948 Apr;39(4):517-35
pubmed: 18123283
Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1955-1963
pubmed: 33616755
Photodiagnosis Photodyn Ther. 2021 Jun;34:102335
pubmed: 33971329
Br J Ophthalmol. 2020 Jan;104(1):104-109
pubmed: 30940619
BMC Ophthalmol. 2017 Apr 11;17(1):45
pubmed: 28399831
Br J Ophthalmol. 2021 Mar;105(3):354-360
pubmed: 32430343
Indian J Ophthalmol. 2022 Oct;70(10):3562-3568
pubmed: 36190047
Neurol Sci. 2022 Aug;43(8):4803-4809
pubmed: 35411501
Br J Ophthalmol. 1952 Apr;36(4):207-10
pubmed: 14916093
Ophthalmic Res. 2023 Jan 5;:
pubmed: 36603555
Ophthalmology. 2020 Dec;127(12):1652-1662
pubmed: 32525046
Br J Ophthalmol. 2023 Jul;107(7):953-958
pubmed: 35101938
Int Ophthalmol. 2021 Jan;41(1):173-184
pubmed: 32851558
Am J Ophthalmol. 2019 Aug;204:51-61
pubmed: 30878489
Arch Ophthalmol. 1982 Mar;100(3):426-31
pubmed: 7065960
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
BMC Ophthalmol. 2022 Aug 10;22(1):339
pubmed: 35948955
Br J Ophthalmol. 2023 Jun;107(6):816-822
pubmed: 35110277
Ophthalmology. 2012 Jun;119(6):1151-8
pubmed: 22365056
Front Med (Lausanne). 2022 Jun 30;9:891369
pubmed: 35847772
J Clin Med. 2021 Oct 28;10(21):
pubmed: 34768535
Int Ophthalmol. 2001;23(4-6):373-9
pubmed: 11944864
Ophthalmology. 2017 Jul;124(7):1056-1064
pubmed: 28408038
J Comp Neurol. 1990 Oct 1;300(1):5-25
pubmed: 2229487